Huge progression of diabetes prevalence and incidence among dialysed patients in Mainland France and overseas French territories. A second national survey six years apart. (UREMIDIAB 2 study)

Diabetes and Metabolism

Volumn 25, Issue 6, 1999, Pages 507-512

  Halimi, S ^a   Zmirou, D ^b   Benhamou, P Y ^b   Balducci, F ^b   Zaoui, Ph ^a   Maghlaoua, M ^a   Cordonnier, D ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Diabetes; End stage renal failure; Epidemiology; Renal replacement therapy

Indexed keywords

AMPUTATION; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; FRANCE; HEART INFARCTION; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FRANCE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; PREVALENCE; RENAL REPLACEMENT THERAPY; WORLD HEALTH;

EID: 0033432670     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Thieler H, Achenbach H, Bischoff J et al. Evolution of renal replacement therapy in East Germany from 1989 to 1992, Nephrol Dial Transplant, 1994, 9, 238-241.
2. Port FK. Worlwide demographics and future trends in end-stage renal disease. Kidney Int. 1993, 41, S4-S7.
3. Canadian Organ Replacement Registry, 1992, Annual Report. Canadian Institute of Health Information: Don Mills, Ontario, 1994.
4. Marcelli D, Spotti D, Conte F et al. Prognosis of diabetic patients on dialysis: Analysis of Lombardy Registry Data. Nephrol Dial Transplant, 1995, 10, 1895-1901.
5. Lippert J, Ritz E, Schwrzbeck A, Schneider P. The rising tide of end-stage renal failure from diabetic nephropathy type II. An epidemiological analysis. Nephrol Dial Transplant, 1995, 10, 462-467.
6. Li L. End stage renal disease in China. Kidney Int, 1996, 287-301.
7. Ritz E, Lippert J, Keller C. Rapider Anstieg der Zahl niereninsuffizienter Typ-II-Diabetiker. Dtsch Med Wschr, 1996, 121, 1247.
8. Mazzuchi N, Schwedt E, Fernández JM, Cusumano AM et al. Latin American Registry of dialysis and renal transplantation: 1993 annual dialysis data report. Nephrol Dial Transplant, 1997, 12, 2521-2527.
9. Rodriguéz JA, Clèries M, Vela E, and Renal Registry Committee: Diabetic patients on renal replacement therapy: analysis of Catalan. Nephrol Dial Transplant, 1997, 12, 2501-2509.
10. Albitar S, Borgeon B, Genin R, et al. On behalf of the Indian Ocean Society of Nephrology. Epidemiology of end-stage renal failure in Reunion Island (results from the registry of the Indian Ocean Society of Nephrology). Nephrol Dial Transplant, 1998, 13, 1143-1145.
11. ANZDATA Registry Report 1997. Australia and New-Zealand Dialysis and Transplant Registry. Ed.: Disney APS, Russ GR, Walker R, Scheil AGR. Adelaide, South Australia, 1998.
12. Danish National Registry Report on Dialysis and Transplantation in Denmark 1997. The Danish Society of Nephrology, 1998.
13. Kikkawa R, Kida Y, Haneda M. Nephropathy in Type II Diabetes -Epidemiological issues as viewed from Japan. Nephrol Dial Transplant, 1998, 13, 2743-2745.
14. Annual report on management of renal failure in Europe, part I., ERA-EDTA Registry, London, 1998.
15. U.S. Renal Data System: USRDS 1998 Annual Data Report. National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Disease, Bethesda, MD, 1998.
16. Excerpts from United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis, 1999, 34 (Suppl 1), S1-176.
17. Ritz E. Nephropathy in type 2 diabetes. Intern Med, 1999, 245, 111-126.
18. Zmirou D, Benhamou PY, Cordonnier D et al. Diabetes mellitus prevalence among dialysed patients in France (UREMIDIAB study). Nephrol Dial Transplant, 1992, 7, 1092-1097.
19. Benhamou PY, Marwah T, Balducci F et al. Classification of diabetes in patients with end-stage renal disease. Validation of clinical criteria according to fasting plasma C-peptide. Clin Nephrol, 1992, 38, 239-244.
20. Borgel F, Benhamou PY, Zmirou D, Balducci F, Halimi S, Cordonnier D. Assessment of handicap in chronic dialysis diabetic patients (Uremidiab section study). Scand J Rehabil Med, 1992, 24, 203-208.
21. Cordonnier DJ, Zmirou D, Benhamou PY, Halimi S, Ledoux F, Guiserix J. Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus. The case of mainland France and of overseas French territories. Diabetologia, 1993, 56, 1109-1112.
22. Cordonnier D, Bayle F, Benhamou PY et al. Future trends of management of renal failure in diabetics. Kidney Int, (Suppl) 1993, 41, S8-13.
23. Verbesserung der Diabetikerversorgung. Fachongreß der Arbeisgruppe Gesundheit der SPD Bundestagsfraktion. 1998.
24. Koch M, Thomas B, Tschöpe W, Ritz E. Survival and predictors of death in dialysed diabetic patients. Diabetologia, 1993, 36, 1113-1117.
25. Hirschl MM. Renal transplantation in patients with type II diabetes mellitus. Nephrol Dial Transplant, 1995, 7, (suppl), 58-60.
26. Hasslacher C, Ritz E, Wahl P, Michael C. Similar risks of nephropathy in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant, 1989, 4, 859-863.
27. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 1998, 552, 837-853.
28. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective. Diabetes Study (UKPDS) Group. Lancet, 1998, 552, 854-865.
29. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.UK Prospective Diabetes Study Group. BMJ, 1998, 317, 703-713.